Module

Screening and Imaging in NSCLC

Source: Research Priorities in Non-Small-Cell Lung Cancer

Screening and Imaging in NSCLC

Faculty:
James R. Jett, MD

CME CREDIT INFORMATION

Release Date: 02/15/07

Expiration Date: 02/14/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.2 contact hours (0.12 CEUs)

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe key clinical trial data regarding computed tomography screening in the setting of NSCLC
Discuss molecular screening tools in NSCLC
Define staging classifications of NSCLC

Topics covered include:

The Premise of Screening
Experience From Early Chest Radiography Screening Trials
Trials Evaluating CT Screening
Molecular Screening Techniques
Categories and Staging in NSCLC
Controversies in Staging and Treatment
WHO and RECIST Guidelines
Volumetric Measurement
Positron Emission Tomography Scanning
Molecular Imaging Probes
Quantum Dot Technology
Research Priorities in Staging and Imaging in NSCLC

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.